Cohort 2: Significant differentially methylated CpG positions between HIV-positive and HIV-negative PBMCs using all 870K CpG sites from the EPIC array from the Women’s Interagency HIV Study.

Cohort 2: Significant differentially methylated CpG positions between HIV-positive and HIV-negative PBMCs using all 870K CpG sites from the EPIC array from the Women’s Interagency HIV Study.队列2：利用妇女艾滋病跨部门研究（Women’s Interagency HIV Study）中EPIC芯片（EPIC array）的全部87万个CpG位点，筛选HIV阳性与HIV阴性外周血单个核细胞（Peripheral Blood Mononuclear Cells，PBMCs）之间的显著差异甲基化CpG位点。